Navigation Links
InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
Date:2/26/2009

$0.8 million in the fourth quarter of 2008, unchanged from the same quarter of 2007.

Research and development (R&D) expenses in the fourth quarter of 2008 were $26.3 million compared with $25.1 million in the fourth quarter of 2007, an increase of 5%. General and administrative (G&A) expenses were $7.8 million in the fourth quarter of 2008, compared with $6.6 million in the same period a year earlier, an increase of 18%.

During the fourth quarter of 2008, InterMune recorded an "other-than-temporary" impairment charge of approximately $3.5 million on its auction-rate securities, reported in the statements of operations.

As of December 31, 2008, InterMune had cash, cash equivalents and available-for-sale securities of approximately $154.7 million.

Results for the 12 Months Ended December 31, 2008

InterMune also reported results from operations for the full year ended December 31, 2008. The net loss for the year was $97.7 million, or $2.51 per share, compared with a net loss of $89.6 million, or $2.52 per share, in 2007.

Total revenue in 2008 was $48.2 million, compared with total revenue of $66.7 million in 2007, a decrease of 28%. Actimmune revenue totaled $29.9 million in 2008, compared with $53.4 million of Actimmune revenue in 2007, a decrease of approximately 44%, reflecting lower off-label sales of Actimmune for the treatment of IPF, which InterMune does not promote. Revenue from the collaboration with Roche was $18.3 million in 2008, compared with $13.3 million in 2007. Collaboration revenue in 2008 consisted of a $15.0 million development milestone and $3.3 million in amortization of the initial upfront and manufacturing milestone payments.

R&D expenses were $104.6 million in 2008, a 1% decrease compared to $105.9 million in 2007. G&A expenses were $30.3 million in 2008, essentially unchanged from $29.6 million in 2007.'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
2. InterMune Announces Issuance of U.S. Patent for ITMN-191
3. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
4. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
5. InterMune to Present at J.P. Morgan Healthcare Conference
6. InterMune to Present at Deutsche Bank Biotech Boston Confab
7. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
8. InterMune to Release Third Quarter 2008 Financial Results on November 6
9. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
10. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
11. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
(Date:5/17/2013)... 17, 2013 RURO Inc. is ... 4.1, a versatile refinement to the smart management ... improves its advanced methodical management for transgenic animal ... 4.1. The network-based platform provides user access with ... While continuing to emphasize streamlined tasks, such as ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Tooth decay is ... showing active signs of the disease. The World Health Organization ... nearly 100% of adults have cavities. What are the long-term ... is showing a strong connection between the oral bacterial imbalance ... this disease so rampant, yet it is also 100% preventable? ...
(Date:5/16/2013)... Oven Industries, Inc. has been an industry ... sensors since 1964. Expertly designed, the proportional-integral-derivative PID ... applications. As one of the most commonly ... loop feedback system, which helps minimize errors. With three-term ... systematic process, using a control element, like a valve ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3New PID Temperature Controllers Announced by Oven Industries Inc. 2
... (Infectious Disease Research,Institute) and Immune Design Corp. announced ... to which Immune Design Corp. is granted a ... of,IDRI,s Glycopyranosyl Lipid Adjuvant (GLA) technology for products ... to fight infectious diseases of,the developing world, IDRI ...
... WWMR, Inc., the marketing research,leader in pain, ... Pain,Drug Company Survey". The top three most ... according to the 100 pain clinic,physicians surveyed in ... for,their knowledgeable, respectful and informed sales representatives, their,sampling/voucher ...
... 20 A US District Court,judge in Oregon yesterday ... & Nephew,s (NYSE: SNN ; LSE: SN) ... of Naples, Fla., from manufacturing or,selling medical devices that ... Dr. John O. Hayhurst of Portland, Ore. The ...
Cached Biology Technology:IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 2US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 3
(Date:5/17/2013)... The State University of New Jersey, and City University ... called Visikol TM that effectively clears organisms to ... place of chloral hydrate, which is one of the ... tightly regulated by the Drug Enforcement Administration (DEA) due ... or clearing agents, are vital for viewing organisms under ...
(Date:5/17/2013)... project (Intelligent Cargo in Efficient and Sustainable Global Logistics ... an improvement in the efficiency of intermodal loading systems ... making. It comprises 29 European organisations with experience in ... has a budget totalling 17,000,000 and a duration of ... to specify and develop the semantic components and ontologies ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... often get bad press, with those found in water ... The University of Nottingham are using these tiny organisms ... and refine water cleaning technology. These one-celled organisms ... is being treated prior to industrial use or even ...
... Think of bacteria eating rock. Now think of bacteria ... on bacteria in that rock 15,000 feet underwater" ... Betty Moore Foundation, USC researcher Katrina Edwards will lead ... Recently discovered subseafloor microbes, which live on chemical ...
... being launched today to tackle some of the most ... which can devastate crop yields across the developing world. ... live in rural areas and most depend on agriculture ... through higher incomes, more and cheaper food, and more ...
Cached Biology News:Bacteria and nanofilters -- the future of clean water technology 2USC awarded $3.9M for lab under the sea 2Major scientific push to tackle agricultural productivity and food security in developing world 2Major scientific push to tackle agricultural productivity and food security in developing world 3
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
Topoisomerase II...
... a positive selection for creating baculovirus recombinants ... insect cells. The kit improves on the ... eliminating the time-consuming steps of plaque purification. ... with a portion of the essential open ...
... The CHEMICON XpressPack™ Colorimetric Detection System ... detection of amplified DNA generated by an ... of a selected target of interest. ... Colorimetric Detection System is a hybridization capture ...
Biology Products: